Identification and external validation of the optimal FIB‐4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings

BACKGROUND: With the initially defined thresholds, the most widely used serum biomarkers for staging liver fibrosis (ie, APRI and FIB‐4 scores) proved to be ineffective among patients with chronic hepatitis B virus infection (CHB). Whether optimizing the FIB‐4 and APRI thresholds could improve their...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Kecheng, Qin, Mengbin, Tao, Kunlin, Liang, Zhihai, Cai, Fuqing, Zhao, Liebin, Peng, Peng, Liu, Shiquan, Zou, Jun, Huang, Jiean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891512/
https://www.ncbi.nlm.nih.gov/pubmed/33146916
http://dx.doi.org/10.1002/jcla.23640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891512/
https://www.ncbi.nlm.nih.gov/pubmed/33146916
http://dx.doi.org/10.1002/jcla.23640

Ejemplares similares